IQGEN-X is a new entrant in the contract research space and is involved in the development of generics, generics plus and branded formulations for regulated markets. The company turned to Cortellis Generic Intelligence™ (formerly known as Newport) to aid in its strategic planning and improve return on investment (ROI).
